Stockscreener 앱 받기
86.73
1.25%
1.06
전일 마감가:
$85.67
열려 있는:
$85.57
하루 거래량:
312.96K
Relative Volume:
0.18
시가총액:
$11.64B
수익:
$3.10B
순이익/손실:
$586.71M
주가수익비율:
20.20
EPS:
4.2937
순현금흐름:
$605.57M
1주 성능:
+0.98%
1개월 성능:
+14.00%
6개월 성능:
-4.25%
1년 성능:
+43.37%
1일 변동 폭
$85.26
$87.16
1주일 범위
$84.46
$88.89
52주 변동 폭
$54.15
$101.40
Globus Medical Inc Stock (GMED) Company Profile
명칭
Globus Medical Inc
전화
610-930-1800
주소
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
86.73 | 11.86B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
116.25 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.75 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.85 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.45 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.54 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | Needham | Hold → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-11-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-11-07 | 업그레이드 | Truist | Hold → Buy |
| 2025-10-28 | 재개 | Stifel | Hold |
| 2025-05-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-19 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-30 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-02-10 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Needham | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-28 | 개시 | Wells Fargo | Overweight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-29 | 개시 | Loop Capital | Buy |
| 2021-02-18 | 재개 | Needham | Buy |
| 2020-12-08 | 개시 | Citigroup | Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2020-08-06 | 재확인 | Needham | Buy |
| 2020-08-06 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 개시 | Northland Capital | Market Perform |
| 2020-07-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 재확인 | Needham | Buy |
| 2020-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-12 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 재확인 | Needham | Buy |
| 2019-05-24 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 재확인 | Needham | Buy |
| 2019-02-28 | 업그레이드 | UBS | Neutral → Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 재확인 | Needham | Buy |
| 2018-04-04 | 업그레이드 | Needham | Hold → Buy |
모두보기
Globus Medical Inc 주식(GMED)의 최신 뉴스
Globus Medical (NYSE:GMED): A Decent Value Stock With Solid Fundamentals - ChartMill
Globus Medical (GMED) Stock Could Be Undervalued Following Margin Gains Update - Yahoo Finance
Globus Medical Inc (GMED) Stock Down 3.0% -- Now Undervalued? GF Score: 95/100 - GuruFocus
Globus Medical Director Stephen T. Zarrilli Executes Stock Options and Sells Shares on August 18, 2026 - Kalkine Media
Globus Medical Director Sold Shares Worth Over $2.1M - TradingView
Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares - Stock Titan
Globus Medical: The Dip Makes It Cheaper, Not Different (NYSE:GMED) - Seeking Alpha
Globus Medical: 7 Quarters Of Margin Expansion, Priced For None (NYSE:GMED) - Seeking Alpha
Globus Medical (NYSE: GMED) insider plans $2.2M sale - Stock Titan
Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice - qz.com
Here is Why Growth Investors Should Buy Globus Medical (GMED) Now - Yahoo Finance
Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)? - Sahm
Globus Medical (GMED) Stock Analysis: Navigating a 20% Potential Upside with Healthcare Innovation - DirectorsTalk Interviews
Assenagon Asset Management S.A. Sells 127,216 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Institutional Ownership 2026 - MarketBeat
Globus Medical Inc (GMED) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views - Yahoo Finance
Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance? - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical (NYSE:GMED) Upgraded at Zacks Research - MarketBeat
Annex Advisory Services LLC Boosts Holdings in Globus Medical, Inc. $GMED - MarketBeat
Q2 2026 Globus Medical, Inc. Earnings Call Transcript - GuruFocus
Nevro, Globus Medical Oppose Bid To Centralize Spinal Cord Stimulator Injury Cases - Mealey's
Globus Medical (GMED) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Bank of America Corp DE Trims Stock Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (GMED) Stock Up 4.6% and Still Undervalued -- GF Score: 97/100 - GuruFocus
Is Globus Medical (GMED) Cheap After Its Earnings Beat And Higher EPS Outlook? - Sahm
Globus Medical, Inc. (GMED) Stock Analysis: A Strong Buy With 25% Upside Potential - DirectorsTalk Interviews
Globus Medical, Inc. (NYSE:GMED) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Results: Globus Medical, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Moomoo
Globus Medical Inc Stock Historical Valuations | BSP:G2ME34 - GuruFocus
Oliver Luxxe Assets LLC Boosts Holdings in Globus Medical, Inc. $GMED - MarketBeat
Polianta Ltd Purchases Shares of 21,000 Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (BSP:G2ME34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Globus Medical Inc Stock Operating Data - GuruFocus
BSP:G2ME34 Dividend: Does Globus Medical Inc Pay a Dividend? - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Price & 30 Year Financial Data - GuruFocus
Globus Medical (BSP:G2ME34) Cyclically Adjusted Price-to-FC - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Who's Buying or Selling Globus Medical Inc (BSP:G2ME34) Stock Today? - GuruFocus
Globus Medical Inc Stock Baskets - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock News, Headlines & Updates - GuruFocus
Globus Medical Inc (BSP:G2ME34) Competitors 2026 - GuruFocus
Globus Medical Inc (BSP:G2ME34) Stock Price, Trades & News - GuruFocus
Globus Medical (NYSE:GMED) Releases Earnings Results, Beats Expectations By $0.24 EPS - MarketBeat
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $85 to $117 - Moomoo
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Globus Medical (GMED) - theglobeandmail.com
Globus Medical Q2 Earnings Call Highlights - MarketBeat
Globus Medical (NYSE:GMED): A Compelling Affordable Growth Opportunity - ChartMill
GMED Q2 Earnings Call Highlights Margin Gains and Revenue Caution - Yahoo Finance
Wells Fargo & Company Lowers Globus Medical (NYSE:GMED) Price Target to $99.00 - marketbeat.com
Globus Medical Inc (GMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.26%
0.20%
자본화:
|
볼륨(24시간):